The role of transforming growth factor-b (TGF-b) receptor complex in the pathogenesis of crescentic glomerulonephritis (GN) is not clear. To test the hypothesis that TGF-b signaling plays a crucial role in the development and progression of crescentic GN by inducing the activation of extracellular signal-regulated kinase (ERK) and expression of its target genes, anti-glomerular basement membrane (GBM) GN was induced in TGF-b type II receptor (TGF-bIIR) gene heterozygous (TGF-bIIR þ /À ) C57BL/6J mice and wild-type animals. GN was initiated in preimmunized mice by administration of rabbit anti-mouse GBM serum. TGF-bIIR deficiency was significantly associated with decreased renal damage at days 14, 21, and 28 after induction of GN: renal function impairment, proteinuria, proportion of crescents, glomerular accumulation of periodic acid-Schiff-positive material, relative cortical interstitial volume, as well as renal cortical phosphorylation of ERK and plasminogen activator inhibitor type I (PAI-1) and a2(I) collagen mRNA levels were significantly decreased in TGF-bIIR þ /À mice compared with wild-type animals. These results provide the first direct evidence that TGF-bIIR deficiency protects against renal injury in crescentic GN, possibly by inhibiting the sustained activation of ERK and PAI-1 and a2(I) collagen gene expression. Thus, TGF-b signaling appears to play an important role in the development and progression of crescentic GN by inducing the ERK activity, and PAI-1 and a2(I) mRNA expression.
Experimental anti-glomerular basement memebrane (GBM) glomerulonephritis (GN) provides a model of a fibrindependent GN, which closely parallels human crescentic GN. Anti-GBM GN results in activation of renal transforming growth factor-b (TGF-b) system early after disease initiation. 1 TGF-b exerts its effects through an interaction with the TGF-b type II receptor (TGF-bIIR) and the type I receptor. 2, 3 Smad proteins are important signaling transducers from those receptors to the target genes, such as plasminogen activator inhibitor type I (PAI-1) and a2(I) collagen. 4 PAI-1 is not expressed in normal kidneys, but is upregulated in human 5, 6 and experimental 7, 8 crescentic GN associated with glomerular fibrin accumulation. Type I collagen is an interstitial collagen, and is expressed in the lesions of interstitial fibrosis and crescents in experimental crescentic GN. 9 Extracellular signal-regulated kinase (ERK), the most readily detectable mammalian mitogen-activated protein (MAP) kinase, is activated in experimental crescentic GN. 10 Whereas the TGF-b receptor transduces the signal through its serine/threonine kinase activity, the MAP kinase pathways have been attributed mainly to growth factor stimulation of protein tyrosine kinases. 11 Nontheless, TGF-b activates ERK in certain cultured cell lines including mesangial cells. [12] [13] [14] [15] Furthermore, ERK contributes to TGF-b1-induced PAI-1 14 or a1(I) collagen 13 expression via synergistic interaction with Smads 14 in cultured human mesangial cells. For maximal Smad activation, TGF-b-induced ERK activity to phosphorylate the linker segments of Smad2/Smad3 [16] [17] [18] is required in mesangial cells. 14 Despite this in vitro data, it is even unknown whether TGF-b induces ERK activation in renal diseases mediated by TGF-b.
Blockade of TGF-b action by adenovirus-mediated gene transfer of TGF-bIIR did not prevent the development of rat anti-GBM GN. 19 Blockade of TGF-b signaling in T cells in Smad7-transgenic mice prevented the development of anti-GBM GN, only in cases receiving a medium dose of anti-GBM antibody but not in those with a high-dose antibody. 20 Thus far, the role of TGF-b/TGF-bIIR in the development and progression of crescentic GN is not clearly defined.
TGF-bIIR gene knockout mice die at embryonic day owing to hematopoietic and vasculogenetic defects in the yolk sac. 21 Thus, using TGF-bIIR gene heterozygous (TGF-bIIR þ /À ) mice could be a useful approach in studying the role of TGF-bIIR in the development and progression of crescentic GN.
We raised the possibility that TGF-bIIR deficiency may suppress the ERK activation and TGF-b target gene expression ameliorating the development and progression of renal injury when anti-GBM GN is induced. To address this question, we compared the severity of renal lesions, and renal expression of phosphorylated ERK and PAI-1 and a2(I) collagen mRNAs between TGF-bIIR þ /À and wild-type mice after the induction of GN.
RESULTS

Clinical characteristics
Injection of nephrotoxic serum induced a significant decrease in body weight at the end of experiment compared with that at day 0 in wild-type mice (Po0.05) ( Figure 1a ). TGF-bIIR þ /À animals, however, showed no significant weight reduction at the end of experiment except for those terminated 14 days after induction of GN ( Figure 1b ).
Injection of nephrotoxic serum induced an increase in daily proteinuria in both strains. However, wild-type animals excreted significantly greater amounts of proteinuria than TGF-bIIR þ /À mice at each time experiment (Figure 2a ).
Most wild-type animals developed renal failure, whereas most TGF-bIIR þ /À mice maintained normal renal function. Blood urea nitrogen (BUN) levels in wild-type mice were significantly higher than those of TGF-bIIR þ /À animals at each time experiment ( Figure 2b ). Concentrations of plasma creatinine were also significantly increased in wild-type mice compared with TGF-bIIR þ /À animals 14-28 days after the induction of GN. At day 7, wild-type mice tended to show higher plasma creatinine levels than TGF-bIIR þ /À animals, but the difference was not statistically significant ( Figure 2c ).
Both the wild type and the TGF-bIIR þ /À control mice showed neither proteinuria nor renal dysfunction throughout the experimental period after injection of rabbit IgG. No difference was shown between the wild type and TGF-bIIR þ /À control mice in the amounts of proteinuria (1.270.6 vs 1.470.7 mg/day), concentrations of BUN (32.775.9 vs 31.676.8 mg/dl), and the levels of plasma creatinine (0.670.08 vs 0.570.06 mg/dl).
Pathology
Both the wild type and the TGF-bIIR þ /À control mice showed no histological abnormalities (Figure 3a and b). After injection of nephrotoxic serum, however, there was a marked difference in histological severity of GN between both genotypes. Most glomeruli in the wild-type mice were abnormal with lesion severity ranging from moderate mesangial hypercellularity to heavy accumulation of periodic acid-Schiff (PAS)-positive material and/or the presence of crescents. Heavy deposits of PAS-positive eosinophilic material that stained positive for fibrin 22 were frequently present in capillary lumens of wild-type mice showing the features of fibrin thrombi ( Figure 3c ). In contrast, TGF-bIIR þ /À mice exhibited either slight mesangial proliferation or modest glomerular changes with lesser PAS-positive material and rare crescent formation at each time experiment ( Figure 3d ).
The mean percentage of the glomeruli affected by the crescents was significantly higher in the wild-type mice compared with TGF-bIIR þ /À animals 14-28 days after the induction of GN (day 14, 53721.2 vs 7.277%; day 21, 58.5723.5 vs 1.471.3%; day 28, 50.5713.4 vs 7.376.9%) (Po0.05). At day 7, wild-type mice tended to have a higher percentage of crescents than TGF-bIIR þ /À mice (5.275 vs 1.871.7%), but the difference was not statistically significant ( Figure 4a ). Glomeruli were graded on a scale of 0-4 for PAS-positive material accumulation. Accumulation of PAS-positive material, which includes cell debris, plasma proteins, immunoglobulin deposits, and fibrin, 22 was significantly greater in wild-type mice compared with TGF-bIIR þ /À mice 14-28 (days after the induction of GN (day 14, 2.970.2 (arbitrary units) vs 0.870.7; day 21, 2.670.8 vs 0.170.1; day 28, 1.871.1 vs 0.670.5) (Po0.05). However, no significant difference was noted between two groups at day 7 ( Figure 4b ).
Tubules from the wild-type animals showed focal atrophy or loss to a variable degree and frequently contained large protein casts with moderate infiltration of leukocytes or collagen laydown in interstitium after the induction of disease ( Figure 3e ). In contrast, TGF-bIIR þ /À mice exhibited either no abnormalities or modest tubulo-interstitial changes (Figure 3f ). The relative renal cortical interstitial volume from TGF-bIIR þ /À mice was significantly decreased than wild-type animals 14-28 days after the induction of GN (day 14, 10.573 vs 3.773.1%; day 21, 975.7 vs 0.470.3%; day 28, 13.178.6 vs 2.372.1%) (Po0.05). However, there was no significant difference in relative interstitial volume between two groups at day 7 ( Figure 4c ).
Immunoblot analysis
Between control animals, no significant difference was shown in renal cortical ERK activities throughout the experimental period after injection of rabbit IgG. At 14-28 days after the induction of GN, however, the cortical ERK activity in wildtype mice was up to sevenfold higher than the TGF-bIIR þ /À animals ( Figure 5 ). At day 7, wild-type mice with GN tended to show increased ERK activity than the TGF-bIIR þ /À mice, but the difference was not statistically significant ( Figure 5 ).
Real-time quantitative reverse transcription-polymerase chain reaction
Analyses of renal cortex showed median threshold cycle (C T ) ¼ 16.83.71.03 for b-actin, and 18.1771.66 for 18S rRNA. Although b-actin was reported to be unsuitable as an internal control in the matrigel-treated cell culture system, 23 we validated that it is a good internal control in this experimental model as it remained constant at all time points and wild type and TGF-bIIR þ /À mice expressed the same amounts of b-actin. We also validated that 18S rRNA used as a parallel internal control to b-actin is a good one in this experiment.
The mRNA content of the renal cortical tissue was analyzed using the 2 ÀDDC T method. 24 In the wild-type mice, PAI-1 mRNA level was significantly increased compared with the TGF-bIIR þ /À mice 7-28 days after the induction of GN. The increase was particularly prominent in the wild-type GN mice at day 14, showing its level up to 130-fold higher than the TGF-bIIR þ /À mice (Figure 6a ). The levels of a2(I) collagen transcript were also significantly increased in the wild-type animals when compared with the TGF-bIIR þ /À mice at each time experiment. Particularly, those in the wild-type GN mice at days 14 and 21 were 15 to 22 times higher than the TGF-bIIR þ /À mice (Figure 6b ).
DISCUSSION
This study demonstrates that the severity of renal injury, and renal ERK activity and PAI-1 and a2(I) collagen mRNA expression are significantly decreased in the TGF-bIIR þ /À mice than the wild-type animals after induction of anti-GBM GN. These results suggest that TGF-bIIR plays an important role in the development and progression of crescentic GN possibly via ERK activation.
We observed that renal cortical activation of ERK was significantly decreased in TGF-bIIR þ /À mice as compared with wild-type animals at 14, 21, and 28 days after induction of GN, suggesting that TGF-b signaling induces a sustained activation of ERK in anti-GBM GN. Although TGF-b is known to activate ERK in cultured mesangial cells, [12] [13] [14] [15] this is the first study demonstrating that TGF-b signaling increases ERK activity in renal diseases mediated by TGF-b. In this study, glomerular ERK activity could not be separately tested because of the limited sample volume. As yet, a significant increase in ERK activity was detected in both the cortical tissue and the glomeruli in rat anti-GBM GN, 10 suggesting that ERK activity in the renal cortex may indirectly reflect that in the glomeruli in this disease.
In vitro studies have shown that ERK signaling pathway plays an important role in the control of cellular proliferation. 25 In human glomerulopathies, ERK-mediated proliferation of mesangial cells and myofibroblasts seems to promote renal fibrosis and disease progression. 26 Activation of ERK resulted in the worsening of renal disease associated with severe proliferative response in remnant kidney model. 27 In this regard, activation of ERK in our wild-type GN mice could induce proliferation of glomerular cells and subsequent renal damage with crescent formation, whereas decreased ERK activity in the TGF-bIIR þ /À mice might result in the opposite effects. Bokemeyer et al. 10 suggested that infiltrating macrophages might contribute to the enhanced ERK activity in rat anti-GBM GN. However, few macrophages showed ERK activation in human glomerulopathies. 26 In this study, renal expression of PAI-1 mRNA was dramatically decreased in the TGF-bIIR þ /À mice than the wild-type animals particularly at day 14 after induction of GN. Although overexpression of PAI-1 has been well established in human 5,6 and experimental 7, 8, 28 crescentic GN, this is the first study demonstrating that activated TGF-b system upregulates PAI-1 transcript in this disease.
Activation of ERK by TGF-b can result in Smad phosphorylation and regulate Smad activation. 16 contributes to the effects of Smad signaling in oxidized lowdensity lipoprotein-or TGF-b1-induced PAI-1 expression in cultured human mesangial cells. 14, 29 Exceptionally, TGF-b1induced nuclear translocation of Smads and their binding to the rat PAI-1 promoter were not affected by ERK kinase inhibitors in rat mesangial cells, which might be attributed to the difference in the PAI-1 promoter sequence between rat and human gene. 15 In this regard, we conjecture that activated ERK in the wild-type mice with GN could induce renal PAI-1 gene overexpression through downstream activation of Smads.
We found that the proportion of crescents and glomerular accumulation of PAS-positive material were strikingly decreased in TGF-bIIR þ /À mice than the wild-type animals with GN. Accumulation of fibrin-containing PAS-positive material within the glomerular tuft leads to an increased propensity toward crescent formation in anti-GBM GN. 22 The plasminogen/plasmin system has important functions in the fibrinolysis. PAI-1 inhibits the activities of tissue-type and urokinase-type plasminogen activator. Thus, enhanced fibrinolytic activity in association with reduced PAI-1 gene expression in our TGF-bIIR þ /À mice might inhibit the glomerular accumulation of PAS-positive material and subsequent crescent formation after the induction of GN.
In this study, a2(I) collagen mRNA expression was significantly attenuated in the TGF-bIIR þ /À mice than the wild-type animals with GN, suggesting that activated TGF-b system upregulates a2(I) collagen transcript in crescentic GN. Similar to PAI-1, TGF-b stimulates a1(I) or a2(I) collagen expression 13, 30 in cultured human mesangial cells via synergistic ERK-Smad interaction. 13 Despite these in vitro data, type I collagen is only present in the lesions of interstitial fibrosis and crescents in experimental crescentic GN. 9 Another interstitial collagen, type III collagen, was also identified in the interstitium and crescents, but not in glomerulus, in human crescentic GN. 31 We also observed that relative renal cortical interstitial volume was significantly decreased in the TGF-bIIR þ /À mice than the wild-type animals with GN. Altogether, TGF-bIIR seems to play an important role in interstitial fibrosis in crescentic GN.
TGF-bIIR þ /À mice also inhibited the progression of diabetic renal injury by suppressing the downstream Smad signaling and subsequent extracellular matrix gene expression. 32 Activation of ERK seems to be related to glomerular matrix expansion in obese Zucker rats. 33 ERK contributes to the effects of Smad signaling in TGF-b1-induced a1(I) and a2(I) collagen or PAI-1 expression in cultured human mesangial cells. 13, 14, 30 Also, TGF-b-induced activation of Ras/ERK MAP kinase signaling can induce TGF-b1 expression, thereby amplifying the TGF-b response and inducing secondary TGF-b responses. 34 Altogether, TGF-bIIR deficiency could protect against renal injury in crescentic GN by inhibiting the ERK activation and subsequent Smad activation and/or secondary TGF-b responses.
Short-term treatment with neutralizing antibody against TGF-b, 35 antisense oligonucleotide, 36 and decorin 37 prevents intrarenal accumulation of extracellular matrix in rats with acute mesangial proliferative GN induced by a single injection of anti-Thy-1.1. SB-525334, an inhibitior of the TGF-b type I receptor, produces significant reductions in renal PAI-1, a1(I), and a1(III) mRNA expression in rats with acute puromycin aminonucleoside nephrosis when compared with vehicle-treated puromycin aminonucleoside nephrosis controls. 38 In this regard, attempts to inhibit the TGF-b signaling in the early stage of crescentic GN merit further attention.
In summary, our results indicate that TGF-bIIR deficiency protects against renal injury in crescentic GN, possibly by inhibiting the sustained ERK activity and PAI-1 and a2(I) collagen gene expression. Thus, TGF-b signaling appears to play a central role in the development and progression of crescentic GN by inducing the activation of ERK and PAI-1 and a2(I) mRNA expression.
MATERIALS AND METHODS Animals
Both the TGF-bIIR þ /À and wild-type C57BL/6J mice were kindly donated by Dr Seong-Jin Kim (Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, MD, USA). TGF-bIIR þ /À mice were generated using TGF-bIIR À/À embryonic stem cell lines, as described previously. 21, 39 TGF-bIIR þ /À embryonic stem cells were injected into blastocysts of each C57BL/6J embryo and the embryos were implanted into pseudo-pregnant carrier mice. The resulting chimeric mice were then analyzed, and TGF-bIIR þ /À mice were bred. In our lab, there have been more than 10 backcrosses in the mice used for this experiment to guarantee that the genetic background of the TGF-bIIR þ /À mice is similar to that of the wild-type mice. The same C57BL/6J mice were used for backcrossing and for wild type. We found that TGF-bIIR þ /À control mice live as long as wild-type control mice with no sign of spontaneous renal pathology. 32 TGF-bIIR þ /À and wild-type mice were fed standard pellet laboratory chow and provided with water ad libitum.
Preparation of anti-mouse GBM serum
Rabbit anti-mouse GBM immune serum was produced as described by Salant and Cybulsky. 40 In brief, minced mice kidneys were sequentially sieved and the glomeruli were collected. After centrifugation, the pellet was resuspended and sonically disrupted. A New Zealand White rabbit was immunized with 10 mg of glomerular sonicates (0.5 ml of the antigen emulsified in complete Freund's adjuvant, 1:1) by multiple subcutaneous injections. Finally, 5 mg of glomerular sonicates was injected into the vein of rabbit ear. The rabbit was bled 10 days after the injection. The rabbit antimouse GBM serum was heat inactivated and filtered through 1.2 mm filters before each intravenous injection.
Induction of anti-GBM GN
Weight-matched TGF-bIIR þ /À or wild-type (TGF-bIIR þ / þ ) mice (24-37 g) were immunized by subcutaneous injection of 0.2 mg of rabbit IgG in 0.2 ml of 1:1 emulsion with complete Freund's adjuvant. Six days later, GN was induced by an intravenous injection of rabbit anti-mouse GBM serum (0.1 ml/20 g body weight) through the tail vein. The intravenous injection was repeated 24 h after the first injection. Mice were killed at day 7 (TGF-bIIR þ / þ , N ¼ 5; TGF-bIIR þ /À , N ¼ 4), day 14 (TGF-bIIR þ / þ , N ¼ 6; TGF-bIIR þ /À , N ¼ 6), day 21 (TGF-bIIR þ / þ , N ¼ 6; TGF-bIIR þ /À , N ¼ 5), and day 28 (TGF-bIIR þ / þ , N ¼ 3; TGF-bIIR þ /À , N ¼ 4) after the first injection of anti-GBM serum. TGF-bIIR þ / þ (N ¼ 12) and TGF-bIIR þ /À (N ¼ 12) control mice were injected with rabbit IgG alone. The kidneys were removed under anesthesia with ether.
Evaluation of proteinuria, plasma creatinine, and BUN Urine was collected during a 24-h period from mice in metabolic cages. During collection, mice were allowed free access to water, but food was withdrawn. Urine protein was quantified using bicinchoninic acid with bovine serum albumin as a standard. At the end of the experiment, the mice were exsanguinated (up to 1 ml blood/ mouse) via aortic puncture under ether anesthesia and plasma was obtained. BUN and plasma creatinine were quantified spectrophotometrically using commercially available kits (Sigma, St Louis, MO, USA).
Pathological study
Midline coronal sections of the kidney were fixed overnight in 4% paraformaldehyde at 41C, embedded in paraffin, and stained with hematoxylin and eosin or PAS. More than 50 glomeruli were examined in each mouse. The percentage of glomeruli showing crescent formation was assessed. Cellular crescent was defined as a lesion consisting of at least two layers of proliferating epithelial and inflammatory cells filling part or all of Bowman's space. PAS-stained sections were scored in a blinded manner using a semiquantitative scale according to the content of PAS-positive material within glomeruli as follows: 0 ¼ no deposition of PAS-positive material, 1 ¼ up to one-fourth of the cross-sectional area of the glomerulus that stained positive, 2 ¼ one-fourth to half involvement, 3 ¼ half to three-fourths involvement, and 4 ¼ greater than three-fourths involvement. A minimum of 20 glomeruli was scored per mouse.
Volume density of renal cortical interstitium (V v(int/cortex) ) was measured in 10 randomly selected areas by the method of pointcounting on the light microscopic sections at a magnification of Â 400 using a 100-point, calibrated, eyepiece grid as we have described previously. 41 We only counted the points lying on interstitial tissue (P i ). Then V v(int/cortex) was calculated from:
Then relative interstitial volume of renal cortex was calculated from:
Relative interstitial volume ð%Þ ¼V vðint=cortexÞ Â100
Immunoblot analysis
Renal cortical lysates were electrophoretically resolved using a 10% polyacrylamide gel in a sodium dodecyl sulfate buffer and then transferred onto nitrocellulose membranes as described previously. 42 The blots were incubated in blocking solution for 1 h and incubated with rabbit anti-ERK1/2 or anti-phosphorylated ERK1/2 (Cell Signaling Technology Inc., Beverly, MA, USA) at 41C overnight. Bound primary antibody was visualized after incubation with horseradish peroxidase-conjugated secondary antibody using an enhanced chemiluminescence system kit (Amersham, Arlington Heights, IL, USA). The intensity of identified bands was quantified by densitometry analysis.
Real-time quantitative reverse transcription-polymerase chain reaction
Total RNA was isolated from the renal cortex and used to synthesize complementary DNA (cDNA) by reverse transcription using reverse transcriptase premix kit (Bioneer, Daejeon, Korea). Oligonucleotide primers for linear amplification were as follows: PAI-1 (GeneBank accession no. M33960), forward 5 0 -ATG AAT TTC CTA GCA GGC CA-3 0 and reverse 5 0 -GGC TGT CCA GTG CAT AAT GA-3 0 ; a2(I) collagen (GeneBank accession no. NM007743), forward 5 0 -CCG TGC TTC TCA GAA CAT CA-3 0 and reverse 5 0 -GAG CAG CCA TCG ACT AGG AC-3 0 ; b-actin (GeneBank accession no. NM007393), forward 5 0 -TCC TAA GAG GAG GAT GGT CG-3 0 and reverse 5 0 -CCT GGG CCA TTC AGA AAT TA-3 0 ; 18S rRNA, 43 forward 5 0 -TCA AGA ACG AAA GTC GGA GGT T-3 0 and reverse 5 0 -GGA CAT CTA AGG GCA TCA CAG-3 0 . Using the cDNA mixture and primers, real-time reverse transcription-polymerase chain reaction was performed on an ABI Prism 7000 (Applied Biosystems, Foster City, CA, USA) with SYBR Green polymerase chain reaction master mix (Takara Korea Biomedical, Seoul, Korea). Two internal controls, b-actin and 18S rRNA, were used in parallel to detect any systematic bias. Cycle conditions were as follows: after an initial hold of 10 s at 941C, the samples were cycled 40 times at 941C for 5 s and 601C for 31 s. Each sample was tested in triplicate and repeated twice. The mRNA content of the renal cortical tissue was analyzed using the 2 ÀDDCT method. 24 The primer for b-actin was cDNAspecific, whereas the assay for 18S rRNA might detect contaminating genomic DNA. 44 In this regard, we compared reverse transcriptasenegative with transcriptase-positive tissues. A DC T of X10 was observed corresponding to a negligible contamination of genomic DNA below 0.1%.
Statistics
Results were presented as mean7s.d. The significance of differences among three or four groups was assessed using analysis of variance. Results between two groups were analyzed by Wilcoxon's rank sum test. A Po0.05 was considered significant.
